APO Research
Talk to an analyst

APO RESEARCH · REPORT

Edaravone Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Edaravone Injection Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchEdaravone Injection Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Edaravone Injection Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Edaravone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edaravone Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Edaravone Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Edaravone Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Edaravone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Edaravone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Edaravone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Edaravone Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Edaravone Injection market include Mitsubishi Tanabe Pharma. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Edaravone Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Edaravone Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Edaravone Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Edaravone Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Edaravone Injection Segment by Company

Mitsubishi Tanabe Pharma

Edaravone Injection Segment by Type

20ml

100ml

Edaravone Injection Segment by Application

Hospital

Pharmacy

Edaravone Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Edaravone Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Edaravone Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Edaravone Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Edaravone Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edaravone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Edaravone Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Edaravone Injection industry.

Chapter 3: Detailed analysis of Edaravone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Edaravone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Edaravone Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Edaravone Injection Industry Trends Table 2. Edaravone Injection Industry Drivers Table 3. Edaravone Injection Industry Opportunities and Challenges Table 4. Edaravone Injection Industry Restraints Table 5. Global Edaravone Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Edaravone Injection Revenue Share by Company (2021-2026) Table 7. Global Edaravone Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Edaravone Injection Sales Volume Share by Company (2021-2026) Table 9. Global Edaravone Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Edaravone Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Edaravone Injection Key Company Manufacturing Base & Headquarters Table 12. Global Edaravone Injection Company, Product Type & Application Table 13. Global Edaravone Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Edaravone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20ml Table 18. Significant Companies of 100ml Table 19. Global Edaravone Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Edaravone Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Edaravone Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Edaravone Injection Sales Volume Share by Type (2021-2026) Table 23. Global Edaravone Injection Sales Volume Share by Type (2027-2032) Table 24. Global Edaravone Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Edaravone Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Edaravone Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Edaravone Injection Sales Value Share by Type (2021-2026) Table 28. Global Edaravone Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Global Edaravone Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Edaravone Injection Sales Volume by Application (2021-2026) & (k units) Table 33. Global Edaravone Injection Sales Volume by Application (2027-2032) & (k units) Table 34. Global Edaravone Injection Sales Volume Share by Application (2021-2026) Table 35. Global Edaravone Injection Sales Volume Share by Application (2027-2032) Table 36. Global Edaravone Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Edaravone Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Edaravone Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Edaravone Injection Sales Value Share by Application (2021-2026) Table 40. Global Edaravone Injection Sales Value Share by Application (2027-2032) Table 41. Global Edaravone Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Edaravone Injection Sales by Region (2021-2026) & (k units) Table 43. Global Edaravone Injection Sales Market Share by Region (2021-2026) Table 44. Global Edaravone Injection Sales by Region (2027-2032) & (k units) Table 45. Global Edaravone Injection Sales Market Share by Region (2027-2032) Table 46. Global Edaravone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Edaravone Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Edaravone Injection Sales Value Share by Region (2021-2026) Table 49. Global Edaravone Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Edaravone Injection Sales Value Share by Region (2027-2032) Table 51. Global Edaravone Injection Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Edaravone Injection Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Edaravone Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Edaravone Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Edaravone Injection Sales by Country (2021-2026) & (k units) Table 56. Global Edaravone Injection Sales Market Share by Country (2021-2026) Table 57. Global Edaravone Injection Sales by Country (2027-2032) & (k units) Table 58. Global Edaravone Injection Sales Market Share by Country (2027-2032) Table 59. Global Edaravone Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Edaravone Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Edaravone Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Edaravone Injection Sales Value Market Share by Country (2027-2032) Table 63. Mitsubishi Tanabe Pharma Company Information Table 64. Mitsubishi Tanabe Pharma Business Overview Table 65. Mitsubishi Tanabe Pharma Edaravone Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolio Table 67. Mitsubishi Tanabe Pharma Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Edaravone Injection Distributors List Table 71. Edaravone Injection Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Edaravone Injection Product Image Figure 2. Global Edaravone Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Edaravone Injection Sales (2021-2032) & (k units) Figure 5. Global Edaravone Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Edaravone Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20ml Image Figure 10. 100ml Image Figure 11. Global Edaravone Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Edaravone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Edaravone Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Edaravone Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Edaravone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Edaravone Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Edaravone Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Edaravone Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Edaravone Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Edaravone Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Edaravone Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Edaravone Injection Sales Value Share by Application (2021-2032) Figure 25. Global Edaravone Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Edaravone Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Edaravone Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Edaravone Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Edaravone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Edaravone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Edaravone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Edaravone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Edaravone Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Edaravone Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Edaravone Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Edaravone Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Edaravone Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Edaravone Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Edaravone Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 20ml
  • 100ml
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Mitsubishi Tanabe Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Edaravone Injection Sales Value (2021-2032)
  4. 1.2.2 Global Edaravone Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Edaravone Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Edaravone Injection Market Dynamics
  1. 2.1 Edaravone Injection Industry Trends
  2. 2.2 Edaravone Injection Industry Drivers
  3. 2.3 Edaravone Injection Industry Opportunities and Challenges
  4. 2.4 Edaravone Injection Industry Restraints
3 Edaravone Injection Market by Company
  1. 3.1 Global Edaravone Injection Company Revenue Ranking in 2025
  2. 3.2 Global Edaravone Injection Revenue by Company (2021-2026)
  3. 3.3 Global Edaravone Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Edaravone Injection Average Price by Company (2021-2026)
  5. 3.5 Global Edaravone Injection Company Ranking (2024-2026)
  6. 3.6 Global Edaravone Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Edaravone Injection Company Product Type and Application
  8. 3.8 Global Edaravone Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Edaravone Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Edaravone Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Edaravone Injection Market by Type
  1. 4.1 Edaravone Injection Type Introduction
  2. 4.1.1 20ml
  3. 4.1.2 100ml
  4. 4.2 Global Edaravone Injection Sales Volume by Type
  5. 4.2.1 Global Edaravone Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Edaravone Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Edaravone Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Edaravone Injection Sales Value by Type
  9. 4.3.1 Global Edaravone Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Edaravone Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Edaravone Injection Sales Value Share by Type (2021-2032)
5 Edaravone Injection Market by Application
  1. 5.1 Edaravone Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Edaravone Injection Sales Volume by Application
  5. 5.2.1 Global Edaravone Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Edaravone Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Edaravone Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Edaravone Injection Sales Value by Application
  9. 5.3.1 Global Edaravone Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Edaravone Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Edaravone Injection Sales Value Share by Application (2021-2032)
6 Edaravone Injection Regional Sales and Value Analysis
  1. 6.1 Global Edaravone Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Edaravone Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Edaravone Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Edaravone Injection Sales by Region (2027-2032)
  5. 6.3 Global Edaravone Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Edaravone Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Edaravone Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Edaravone Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Edaravone Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Edaravone Injection Sales Value (2021-2032)
  12. 6.6.2 North America Edaravone Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Edaravone Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Edaravone Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Edaravone Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Edaravone Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Edaravone Injection Sales Value (2021-2032)
  21. 6.9.2 South America Edaravone Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Edaravone Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Edaravone Injection Sales Value Share by Country, 2025 VS 2032
7 Edaravone Injection Country-level Sales and Value Analysis
  1. 7.1 Global Edaravone Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Edaravone Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Edaravone Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Edaravone Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Edaravone Injection Sales by Country (2027-2032)
  6. 7.4 Global Edaravone Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Edaravone Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Edaravone Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Edaravone Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Edaravone Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Edaravone Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Edaravone Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Edaravone Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Edaravone Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Edaravone Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Edaravone Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Edaravone Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Edaravone Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Edaravone Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Edaravone Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Edaravone Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Edaravone Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Edaravone Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Edaravone Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Edaravone Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Edaravone Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Edaravone Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Edaravone Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Edaravone Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Edaravone Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Edaravone Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Edaravone Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Edaravone Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Edaravone Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Edaravone Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Edaravone Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Edaravone Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Edaravone Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Edaravone Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mitsubishi Tanabe Pharma
  2. 8.1.1 Mitsubishi Tanabe Pharma Company Information
  3. 8.1.2 Mitsubishi Tanabe Pharma Business Overview
  4. 8.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mitsubishi Tanabe Pharma Edaravone Injection Product Portfolio
  6. 8.1.5 Mitsubishi Tanabe Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Edaravone Injection Value Chain Analysis
  2. 9.1.1 Edaravone Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Edaravone Injection Sales Mode & Process
  6. 9.2 Edaravone Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Edaravone Injection Distributors
  9. 9.2.3 Edaravone Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst